Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?
Authors:
Open Access
- 1 May 2005
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (5) , 1099-1102
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyJournal of Thrombosis and Haemostasis, 2003
- Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?The Lancet, 2003
- Duration of Prophylaxis Against Venous Thromboembolism With Fondaparinux After Hip Fracture SurgeryA Multicenter, Randomized, Placebo-Controlled, Double-blind StudyArchives of internal medicine (1960), 2003
- Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBritish Journal of Surgery, 2001
- Natural History of Thromboembolic Disease After Total Hip ArthroplastyClinical Orthopaedics and Related Research, 1996
- Surrogate endpoints: A basis for a rational approachEuropean Journal of Clinical Pharmacology, 1992
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Evaluation of 125I-fibrinogen test for venous thrombosis in patients with hip fractures: comparison between isotope scanning and necropsy findings.BMJ, 1977
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972
- NATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSISThe Lancet, 1969